Produkty 571-25-5

CAS 571-25-5 występuje w naszej ofercie pod nazwami: (17Beta)-17-Hydroxyandrost-5-en-3-one, (17beta)-17-Hydroxyandrost-5-en-3-one, >95% (HPLC). Oferty producentów: Biosynth, TRC. Dostępne opakowania: 500mg, 50mg, 5mg.

(17Beta)-17-Hydroxyandrost-5-en-3-one
Biosynth
  • opakowanie: 500mg
  • Warianty: 1
Zobacz produkt
(17beta)-17-Hydroxyandrost-5-en-3-one, >95% (HPLC)
TRC
  • opakowanie: 50mg, 5mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 571-25-5) to związek chemiczny o wzorze sumarycznym C19H28O2 i masie molowej 288.4 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: SEDRVEWTPRTLOZ-DYKIIFRCSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O2
Masa molowa288.4 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeySEDRVEWTPRTLOZ-DYKIIFRCSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC=C4[C@@]3(CCC(=O)C4)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 17beta-hydroxy-5-androsten-3-one, 5-Androsten-17beta-ol-3-one, (17beta)?-?17-?Hydroxyandrost-?5-?en-?3-?one, 17b-hydroxyandrost-5-en-3-one, SEDRVEWTPRTLOZ-DYKIIFRCSA-N, 5-Androsten-17.beta.-ol-3-one, 17-Hydroxyandrost-5-en-3-one #, Androst-5-en-17.beta.-ol-3-one, 17beta-hydroxy-androst-5-ene-3-one, (17?)?-?17-?Hydroxyandrost-?5-?en-?3-?one
Izomery (ten sam wzór sumaryczny)
(3S,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H28O2
(4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenoic acid C19H28O2
(3R,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3R,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3R,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(8R,9S,10R,13S,14S,17S)-13-ethyl-17-hydroxy-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C19H28O2
(3S,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3bR,5aS,9aS,9bS)-1,1,9a-trimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O2
(8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H28O2
(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O2